Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease

Hypertension and chronic kidney disease (CKD) are among the most common comorbidities associated with coronavirus disease 2019 (COVID-19) severity and mortality risk. Renin–angiotensin system (RAS) blockers are cornerstones in the treatment of both hypertension and proteinuric CKD. In the early mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Theodorakopoulou, Marieta P, Alexandrou, Maria-Eleni, Boutou, Afroditi K, Ferro, Charles J, Ortiz, Alberto, Sarafidis, Pantelis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754739/
https://www.ncbi.nlm.nih.gov/pubmed/35198155
http://dx.doi.org/10.1093/ckj/sfab272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754739/
https://www.ncbi.nlm.nih.gov/pubmed/35198155
http://dx.doi.org/10.1093/ckj/sfab272

Ejemplares similares